Roche to give featured talk at Protein Kinases meeting May 27-28, Boston
MONROVIA, CA â€' David M. Goldstein, Senior Director and Head of Inflammation Chemistry at Hoffmann-La Roche to speak at GTCbioâ€™s 5th Protein Kinases in Drug Discovery conference May 27-28, 2010 in Boston, MA.
David M. Goldstein will give a featured presentation on â€śUsing In-Vitro Assays, including Kinase Selectivity Profiles, to Predict Toxicity In-Vivoâ€ť. Internal experience with kinase inhibitors has identified multiple safety liabilities which often manifest themselves only after prolonged treatment in vivo. At Roche, an initiative between chemistry, research informatics and safety was established to create predictive tools to improve their current attrition rate.
Benefits of Dr. Goldsteinâ€™s presentation include:
â€˘ Robust toxicity of kinase inhibitors can be leveraged to validate new in-vitro assays
â€˘ Demonstrate how kinase inhibition profiles can be utilized to predict toxicities
â€˘ Early safety information can help project teams make decisions faster and more efficiently
David M. Goldstein received his Ph.D. in organic chemistry from the Department of Chemistry at the University of Virginia in 1992. From 1992-1994, he completed post-doctoral studies in organic chemistry at the University of Pittsburgh under the direction of Prof. Peter Wipf. In 1994, he joined Syntex in Palo Alto, California and continued on with Roche in 1995. Currently, he is a Senior Director and the Head of Inflammation Chemistry at Roche in Nutley, New Jersey. Davidâ€™s research is focused on the discovery of small molecule inhibitors in the areas of inflammatory, respiratory and autoimmune diseases. David has an active interest in the development of new in-vitro tools to enable early safety profiling of drug candidates.
Also presenting at the Protein Kinase conference are prestigious organizations including AstraZeneca, Bristol-Myers Squibb, Dana-Farber, Dartmouth, Genentech, GlaxoSmithKline, Harvard, Roche, Merck, Pfizer, Tufts, UCSD, Wyeth and other leaders in the kinase industry.
The 5th Protein Kinases in Drug Discovery conference features presentations on new technology for kinase target and inhibitor identification and screening, kinase selectivity, kinase drug design, kinase targets & inhibitors in oncology, kinase targets & inhibitors in CNS disorders, and kinase targets & inhibitors in inflammatory disorders. For more information, visit http://www.gtcbio.com.
User comments, Ratings and Reviews
[Bookmark & read later
/ Comment this story ]
GTCbio from 117.196.231.xxx
Article Taged as : roche, give, featured, talk, protein, kinases, meeting, 27-28,, boston, http, www.gtcbio.com, roche, give, featured, talk, protein, kinases, meeting, 27-28,, boston,
Article Viewed 3084 times.
Positive attitude 1 votes [0%]
Negetive attitude 1 votes [0%]
News Article Source & Groups
You can find this article under group.
And brought to you by Channel ,
The XMl Feed Type and collected data bytes sized news and still counting.
Feed Server name is and Code Page (Not Defined/Un Known)
: : Roche to give featured talk at Protein Kinases meeting May 27-28, Boston
Date Listed : Sunday, March 14, 2010
Source : ,
- Boston area Intellectual Property Firm Patents Etcetera Announces a.Patents Etcetera announces a novel fire-fighting device, the Grantham MechVent™, designed to minimize the possibility of flashover during a building fire.(PRWeb February 17, 2012)Read the full story at http://www.prweb.com/releases/firefighting/granthammechvent/prweb9189891.htm
- Neurodegenerative diseases Ring like structure found in elongator protein complex A ring-like structure found in a protein complex called Elongator' provides new clues to its tasks inside the cell and to its role in neurodegenerative diseases. It is the first ...
- Protein that sends painful touch signals identified Researchers report that they have identified a class of proteins that detect "painful touch." Scientists have known that sensory nerves in our skin detect pressure, pain, heat, cold, and other ...
- A single protein helps the body keep watch over the Epstein Barr virus Some 90 percent of people are exposed to the Epstein Barr virus at some point in their life. Even though it is quickly cleared from the body, the virus can ...
- Caltech scientists uncover structure of key protein in common HIV subgroup PASADENA, Calif. -- Scientists from the California Institute of Technology (Caltech) have provided the first-ever glimpse of the structure of a key protein -- gp120 -- found on the surface ...
- Multivariate SPC and Stability Analysis Shelf Life Prediction Featured in NWA Quality Analyst® Version 6.2 Northwest Analytical, Inc. introduces the next generation of Quality Analytics with NWA Quality Analyst® Version 6.2 which provides improved performance, new tools for breaking down data, and two ...
- New Quest Energy Efficient Home By Modular Lifestyles Inc. To Be Featured Attraction at Sacramento Green Expo April 24 25 2010 Modular Lifestyles, Inc. will be revealing their first-of-it's-kind "Quest" Energy Efficient factory built home at the upcoming Sacramento Green Expo. Utilizing state-of-the-art technologies, the Quest home exceeds California UBC ...
- New method for producing proteins critical to medical research Scientists have developed a new method for producing proteins critical to research on cancer, Alzheimer's, and other diseases. The chemical method yields hundreds-fold more ubiquitylated proteins than current approaches. Such ...
- Melamine in milk Tiny gold particles help researchers find protein impostorResearchers have developed a fast, economical and easy method to detect melamine in milk, using gold nanoparticles.
- Dangerous plaques in blood vessels rupture by overproducing protein busting enzymesSEATTLE -- University of Washington (UW) researchers have gathered evidence that dangerous plaques in blood vessels can rupture by overproducing protein-digesting enzymes. Plaques are fat-laden...